Integrated Wealth Counsel’s Novartis NVS Stock Holding History

Integrated Wealth Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$146K	Hold	2,230	–	–	0.31%	38
2016 Q3	$158K	Buy	2,230 +270	+14%	+$19.7K	0.33%	36
2016 Q2	$145K	Hold	1,960	–	–	0.33%	30
2016 Q1	$127K	Hold	1,960	–	–	0.29%	32
2015 Q4	$151K	Hold	1,960	–	–	0.24%	28
2015 Q3	$161K	Hold	1,960	–	–	0.27%	26
2015 Q2	$173K	Hold	1,960	–	–	0.24%	28
2015 Q1	$173K	Hold	1,960	–	–	0.22%	32
2014 Q4	$163K	Buy	+1,960	New	+$162K	0.2%	30
2014 Q2	–	Sell	-223	Closed	-$17K	–	135
2014 Q1	$17K	Sell	223 -218	-49%	-$15.9K	0.01%	125
2013 Q4	$32K	Buy	441 +223	+102%	+$15.5K	0.02%	118
2013 Q3	$15K	Hold	218	–	–	0.01%	148
2013 Q2	$14K	Buy	+218	New	+$14.2K	0.01%	148

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Integrated Wealth Counsel's NVS Position: Q4 2016 in Review

Integrated Wealth Counsel held its Novartis (NVS) position steady in Q4 2016 at 2,230 shares worth $146K. The position accounts for 0.31% of the portfolio, ranked #38.

Integrated Wealth Counsel first reported a position in NVS in Q2 2013 and has held it in 13 quarters since. The position peaked at $173K in Q2 2015. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Integrated Wealth Counsel held 2,230 shares of Novartis worth $146K as of Q4 2016.
Integrated Wealth Counsel left its Novartis share count unchanged in Q4 2016.
Novartis made up 0.31% of Integrated Wealth Counsel's portfolio in Q4 2016, its #38 holding.
Integrated Wealth Counsel first reported a position in Novartis in Q2 2013 and has held it in 13 quarters since.
Integrated Wealth Counsel's Novartis position peaked at $173K in Q2 2015.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.